(Q84497468)
Statements
Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents (English)
Wen-ying Yang
Qiu-he Ji
Da-long Zhu
Jin-kui Yang
Lu-lu Chen
Zhi-min Liu
De-min Yu